Etienne Sibille: Investigating the cellular and molecular bases of depression and aging for innovative therapeutics

Etienne Sibille, a pioneering figure in neuropsychiatric research, has yet to follow conventional paths. From his early days as a photojournalist editor in New York to becoming one of neuroscience's most innovative voices, his journey reflects the same creative thinking that drives his groundbreaking research at the University of Toronto. As a Professor of Psychiatry, Pharmacology & Toxicology, he brings a fresh perspective to understanding how our brains age and why we get depressed. At the Center for Addiction and Mental Health (CAMH), where he directs the Neurobiology of Depression and Aging research program, his team is turning fascinating discoveries about brain chemistry into potential new treatments. Building on his influential work at Columbia University and the University of Pittsburgh, Sibille has challenged traditional views of brain disorders, particularly through his insights into the GABAergic system and aging. While serving as CAMH's Campbell Chair (2014–2024) and Deputy Director of the Campbell Institute (2017–2020), he has pushed the boundaries between basic research and real-world treatments, recently diving into biopharma development to help bridge this gap. In this Genomic Press Interview, he shares the winding road that led him from behind a camera lens to the forefront of psychiatric research, offering a candid look at what drives his passion for unraveling the brain's mysteries.